Blue Trust Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $422K | Buy |
1,293
+135
| +12% | +$44K | 0.01% | 511 |
|
|
2025
Q1 | $313K | Buy |
1,158
+293
| +34% | +$79.1K | ﹤0.01% | 553 |
|
|
2024
Q4 | $204K | Buy |
865
+403
| +87% | +$94.8K | ﹤0.01% | 652 |
|
|
2024
Q3 | $112K | Buy |
462
+375
| +431% | +$91.1K | ﹤0.01% | 1158 |
|
|
2024
Q2 | $13K | Buy |
87
+72
| +480% | +$10.8K | ﹤0.01% | 1833 |
|
|
2024
Q1 | $2.24K | Sell |
15
-27
| -64% | -$4.04K | ﹤0.01% | 1803 |
|
|
2023
Q4 | $7K | Sell |
42
-59
| -58% | -$9.83K | ﹤0.01% | 1692 |
|
|
2023
Q3 | $19K | Buy |
101
+10
| +11% | +$1.88K | ﹤0.01% | 1191 |
|
|
2023
Q2 | $18K | Sell |
91
-15
| -14% | -$2.97K | ﹤0.01% | 1075 |
|
|
2023
Q1 | $25K | Sell |
106
-2
| -2% | -$472 | ﹤0.01% | 1282 |
|
|
2022
Q4 | $21K | Buy |
108
+87
| +414% | +$16.9K | ﹤0.01% | 1271 |
|
|
2022
Q3 | $3K | Buy |
21
+8
| +62% | +$1.14K | ﹤0.01% | 1661 |
|
|
2022
Q2 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 1625 |
|